Zhao W, Ke S, Cai X, Zuo Z, et al. Radiotherapy plus camrelizumaband irinotecan for oligometastatic esophageal squamous cell carcinoma patients after first-line immunotherapy plus chemotherapy failure: An open-label, single-arm, phase II trial. Radiother Oncol 2023 Apr 25:109679. doi: 10.1016/j.radonc.2023.109679.
PMID: 37105302